BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22079192)

  • 21. Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies.
    Vartdal F; Vandvik B
    Clin Exp Immunol; 1983 Dec; 54(3):641-7. PubMed ID: 6317243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
    Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
    Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
    Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis.
    Rand KH; Houck H; Denslow ND; Heilman KM
    J Neurol Sci; 2000 Feb; 173(1):32-9. PubMed ID: 10675577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved methods for the application of random peptide phage libraries to the study of the oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis.
    Rand KH; Houck H
    J Neurosci Methods; 2000 Sep; 101(2):131-9. PubMed ID: 10996373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligoclonal bands and antibody responses in multiple sclerosis.
    Correale J; de los Milagros Bassani Molinas M
    J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
    Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis.
    Niino M; Sato S; Fukazawa T; Yoshimura S; Hisahara S; Matsushita T; Isobe N; Yoshida K; Houzen H; Miyazaki Y; Shimohama S; Kikuchi S; Kira J
    Mult Scler; 2015 Aug; 21(9):1112-20. PubMed ID: 25583844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion.
    Calais G; Forzy G; Crinquette C; Mackowiak A; de Seze J; Blanc F; Lebrun C; Heinzlef O; Clavelou P; Moreau T; Hennache B; Zephir H; Verier A; Neuville V; Confavreux C; Vermersch P; Hautecoeur P
    Mult Scler; 2010 Jan; 16(1):87-92. PubMed ID: 20028709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis. Electrofocused "bands" of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses.
    Vartdal F; Vandvik B
    J Neurol Sci; 1982 Apr; 54(1):99-107. PubMed ID: 6281394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
    Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J
    Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isotachophoresis evaluation of synthesis of intrathecal IgG subfractions in multiple sclerosis.
    Zaffaroni M; Caputo D; Cazzullo CL
    J Neurol; 1983; 229(1):55-60. PubMed ID: 6189977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.
    Holmøy T; Vandvik B; Vartdal F
    Mult Scler; 2003 Jun; 9(3):228-34. PubMed ID: 12814167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis.
    Mattson DH; Roos RP; Arnason BG
    Ann Neurol; 1981 Jan; 9(1):34-41. PubMed ID: 6163394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis.
    Alenda R; Álvarez-Lafuente R; Costa-Frossard L; Arroyo R; Mirete S; Álvarez-Cermeño JC; Villar LM
    Eur J Neurol; 2014 Aug; 21(8):1096-1101. PubMed ID: 24724742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
    Stich O; Kluge J; Speck J; Rauer S
    Acta Neurol Scand; 2015 Jun; 131(6):381-8. PubMed ID: 25402869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relation between the clinical and cerebrospinal fluid parameters in multiple sclerosis, with special reference to subjects without oligoclonal IgG in the cerebrospinal fluid].
    Poloni M; Rocchelli B; Mazzarello P; Delodovici M
    Riv Neurol; 1981; 51(2):69-80. PubMed ID: 7244541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis.
    Lin MW; Suan D; Lenton K; Henniker T; Burke T; Vucic S; Fulcher DA
    Pathology; 2012 Apr; 44(3):248-50. PubMed ID: 22406478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library.
    Yu X; Gilden DH; Ritchie AM; Burgoon MP; Keays KM; Owens GP
    J Neuroimmunol; 2006 Mar; 172(1-2):121-31. PubMed ID: 16371235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.